Summaries & Associations of Study Results
TR-330 4-Hexylresorcinol
Target Organs and Levels of Evidence
NTP Technical Report Number 330
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| 4-HEXYLRESORCINOL 136-77-6 |
03/04/87 | ANTHELMINTIC, TOPICAL ANTISEPTIC | Gavage 0,62.5,125 MG/KG/50 PER GROUP | Physiological Research Laboratory |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: NO EVIDENCE | ||||
| FR: NO EVIDENCE | ||||
| MM: EQUIVOCAL EVIDENCE | ADRENAL GLAND MEDULLA: PHEOCHROMOCYTOMA 1/50 2/50 5/49 | |||
| HARDERIAN GLAND: ADENOMA 0/50 0/50 1/50 OR CARCINOMA 0/50 4/50 2/50 COMBINED 0/50 4/50 3/50 | ||||
| FM: NO EVIDENCE | ||||
Web page last updated on February 10, 2006
